India’s CDSCO approves generics of Favipiravir and Remdesivir for Covid-19 treatment
Following the approval from the drug regulator, Glenmark Pharmaceuticals has launched the generic version of oral antiviral drug Favipiravir under the brand name of FabiFlu. Favipiravir was developed